Cargando…
Mechanisms of Diabetic Nephropathy Not Mediated by Hyperglycemia
Diabetes mellitus (DM) is characterized by the appearance of progressive kidney damage, which may progress to end-stage kidney disease. The control of hyperglycemia is usually not sufficient to halt this progression. The kidney damage is quantitatively and qualitatively different in the two forms of...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650633/ https://www.ncbi.nlm.nih.gov/pubmed/37959313 http://dx.doi.org/10.3390/jcm12216848 |
_version_ | 1785135825447550976 |
---|---|
author | Viggiano, Davide |
author_facet | Viggiano, Davide |
author_sort | Viggiano, Davide |
collection | PubMed |
description | Diabetes mellitus (DM) is characterized by the appearance of progressive kidney damage, which may progress to end-stage kidney disease. The control of hyperglycemia is usually not sufficient to halt this progression. The kidney damage is quantitatively and qualitatively different in the two forms of diabetes; the typical nodular fibrosis (Kimmelstiel Wilson nodules) appears mostly in type 1 DM, whereas glomerulomegaly is primarily present in type 2 obese DM. An analysis of the different metabolites and hormones in type 1 and type 2 DM and their differential pharmacological treatments might be helpful to advance the hypotheses on the different histopathological patterns of the kidneys and their responses to sodium/glucose transporter type 2 inhibitors (SGLT2i). |
format | Online Article Text |
id | pubmed-10650633 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106506332023-10-30 Mechanisms of Diabetic Nephropathy Not Mediated by Hyperglycemia Viggiano, Davide J Clin Med Review Diabetes mellitus (DM) is characterized by the appearance of progressive kidney damage, which may progress to end-stage kidney disease. The control of hyperglycemia is usually not sufficient to halt this progression. The kidney damage is quantitatively and qualitatively different in the two forms of diabetes; the typical nodular fibrosis (Kimmelstiel Wilson nodules) appears mostly in type 1 DM, whereas glomerulomegaly is primarily present in type 2 obese DM. An analysis of the different metabolites and hormones in type 1 and type 2 DM and their differential pharmacological treatments might be helpful to advance the hypotheses on the different histopathological patterns of the kidneys and their responses to sodium/glucose transporter type 2 inhibitors (SGLT2i). MDPI 2023-10-30 /pmc/articles/PMC10650633/ /pubmed/37959313 http://dx.doi.org/10.3390/jcm12216848 Text en © 2023 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Viggiano, Davide Mechanisms of Diabetic Nephropathy Not Mediated by Hyperglycemia |
title | Mechanisms of Diabetic Nephropathy Not Mediated by Hyperglycemia |
title_full | Mechanisms of Diabetic Nephropathy Not Mediated by Hyperglycemia |
title_fullStr | Mechanisms of Diabetic Nephropathy Not Mediated by Hyperglycemia |
title_full_unstemmed | Mechanisms of Diabetic Nephropathy Not Mediated by Hyperglycemia |
title_short | Mechanisms of Diabetic Nephropathy Not Mediated by Hyperglycemia |
title_sort | mechanisms of diabetic nephropathy not mediated by hyperglycemia |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650633/ https://www.ncbi.nlm.nih.gov/pubmed/37959313 http://dx.doi.org/10.3390/jcm12216848 |
work_keys_str_mv | AT viggianodavide mechanismsofdiabeticnephropathynotmediatedbyhyperglycemia |